Reactive angioendotheliomatosis revealing a glomerulopathy secondary to a monoclonal gammopathy successfully treated with lenalidomide
J Eur Acad Dermatol Venereol
.
2021 Feb;35(2):e115-e118.
doi: 10.1111/jdv.16840.
Epub 2020 Aug 17.
Authors
Y Di Filippo
1
,
N Cardot-Leccia
2
,
E Long-Mira
3
,
M Andreani
4
,
V Richez
5
,
J-P Lacour
1
,
T Passeron
1
6
,
H Montaudié
1
6
Affiliations
1
Dermatology Department, Université Côte d'Azur, CHU Nice, Nice, France.
2
Department of Histopathology Laboratory Central of Pathology, Université Côte d'Azur, CHU Nice, Nice, France.
3
Laboratory of Clinical and Experimental Pathology, Université Côte d'Azur, CHU Nice, France.
4
Nephrology Department, Université Côte d'Azur, CHU Nice, Nice, France.
5
Hematology Department, Université Côte d'Azur, CHU Nice, Nice, France.
6
INSERM, U1065, Centre Méditerranéen de Médecine Moléculaire, Université Côte d'Azur, Nice, France.
PMID:
32735354
DOI:
10.1111/jdv.16840
No abstract available
Publication types
Letter
MeSH terms
Hemangioendothelioma*
Humans
Lenalidomide / therapeutic use
Paraproteinemias* / complications
Paraproteinemias* / drug therapy
Skin Neoplasms*
Substances
Lenalidomide
Supplementary concepts
Reactive angioendotheliomatosis